Hearing News Watch

COLUMBIA, SOUTH CAROLINA — Older adults who maintain higher levels of physical function may also be more likely to retain better hearing, according to a new study from researchers at the University of South Carolina and collaborating institutions. Published in Scientific Reports, the study examined the relationships among physical function, systolic blood pressure, hearing sensitivity, and cognition in 150 community-dwelling

SEONGNAM, SOUTH KOREA — South Korean biotechnology company Rznomics has received an additional research payment from Eli Lilly and Company under the companies’ ongoing collaboration to develop RNA-editing therapies for hereditary hearing loss, according to multiple Korean media reports citing the company. The development was first reported by Seoul Economic Daily, one of South Korea’s leading business publications, which reported that Rznomics

INNSBRUCK, AUSTRIA — Hearing plays a fundamental role in everyday life, helping people stay connected, safe, and engaged with the world around them. Yet despite its importance, fewer than 3 in 10 Americans believe society knows enough about hearing loss. A new survey conducted by MED-EL, a global leader in hearing implant solutions, reveals a gap between how strongly people in

WHITE BEAR LAKE, MINNESOTA — Envoy Medical Inc. (NASDAQ: COCH) announced that all 56 patients enrolled in its pivotal clinical trial of the investigational Acclaim® cochlear implant have completed their three-month follow-up visits. The milestone follows the company’s recent announcement that all 56 study participants had been successfully activated with the Acclaim device, marking another step forward in the pivotal

Cochlear implants have transformed the lives of hundreds of thousands of people with severe hearing loss, but the devices do require surgery and have inherent limitations, including the spread of electrical stimulation within the cochlea. Researchers have long sought ways to stimulate the auditory system more precisely while reducing the need for invasive procedures. A new study from Doshisha University

MUNICH/FRANKFURT, GERMANY — Munich Airport is partnering with Sittig Technologies to pilot Auracast™ broadcast audio at six gates across Terminal 1 and Terminal 2. The pilot began July 14, 2026. The project is intended to make airport announcements more accessible and personalized by allowing passengers to receive live gate information directly through compatible hearing aids, cochlear implants, headphones, or earbuds. A

SEATTLE, WASHINGTON — Sound Pharmaceuticals announced that it has completed enrollment in its second Phase 3 open-label study of SPI-1005 for the treatment of Ménière’s disease (MD). SPI-1005, an investigational oral anti-inflammatory drug, received FDA Breakthrough Therapy Designation in late 2025. Ménière’s disease is a complex inner ear disorder involving low- to mid-frequency hearing loss, tinnitus, vertigo, and dizziness. According

ALBUQUERQUE, NEW MEXICO — Auracast™, a new Bluetooth® technology capable of transmitting audio to a nearly unlimited number of receivers simultaneously, has arrived in Albuquerque. Grace Lutheran Church and Albuquerque Hearing and Balance—both early adopters of hearing loop assistive listening technology—are among the first known organizations in the area to deploy the emerging audio broadcast technology. At both locations, Auracast supplements

Auditdata is continuing to invite hearing care professionals across the United States to participate in its industry-wide survey examining the staffing shortage and administrative burden facing hearing care clinics. The survey seeks input from clinic owners, practice managers, and audiologists to better understand where clinician time is being lost and what factors are contributing to burnout — helping build an

VIENNA, VIRGINIA — The American Tinnitus Association (ATA) has announced the creation of ATA Academy, a comprehensive online education platform designed to improve tinnitus care by providing evidence-based training for healthcare professionals across multiple disciplines. Expected to launch in early 2027, the initiative aims to address one of the greatest challenges facing people with tinnitus today: the limited availability of